139 related articles for article (PubMed ID: 37877514)
21. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
[TBL] [Abstract][Full Text] [Related]
22. Three nested randomized controlled trials of peer-only or multiple stakeholder group feedback within Delphi surveys during core outcome and information set development.
Brookes ST; Macefield RC; Williamson PR; McNair AG; Potter S; Blencowe NS; Strong S; Blazeby JM
Trials; 2016 Aug; 17(1):409. PubMed ID: 27534622
[TBL] [Abstract][Full Text] [Related]
23. Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report.
Tonetti MS; Sanz M; Avila-Ortiz G; Berglundh T; Cairo F; Derks J; Figuero E; Graziani F; Guerra F; Heitz-Mayfield L; Jung RE; Lai H; Needleman I; Papapanou PN; Sailer I; Sanz-Sanchez I; Schwarz F; Shi J; Thoma D
J Clin Periodontol; 2023 May; 50 Suppl 25():5-21. PubMed ID: 37143289
[TBL] [Abstract][Full Text] [Related]
24. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Trials; 2014 Dec; 15():511. PubMed ID: 25540987
[TBL] [Abstract][Full Text] [Related]
25. Development of an updated, standardized, patient-centered outcome set for lung cancer.
de Rooij BH; van den Hurk C; Smaardijk V; Fernandez-Ortega P; Navarro-Martin A; Barberio L; Guckenberger M; Schmid S; Walraven I; Vallow S; Kotsi C; Preusser M; Mosor E; Klok JM; Becker A; Milani A; Ninov L; van de Poll-Franse LV
Lung Cancer; 2022 Nov; 173():5-13. PubMed ID: 36103777
[TBL] [Abstract][Full Text] [Related]
26. Creating a comprehensive research strategy for cutaneous neurofibromas.
Blakeley JO; Wolkenstein P; Widemann BC; Lee J; Le LQ; Jackson R; Stathis M; Verma SK
Neurology; 2018 Jul; 91(2 Suppl 1):S1-S4. PubMed ID: 29987129
[TBL] [Abstract][Full Text] [Related]
27. A Core Outcome Set for Research Evaluating Interventions to Prevent and/or Treat Delirium in Critically Ill Adults: An International Consensus Study (Del-COrS).
Rose L; Burry L; Agar M; Campbell NL; Clarke M; Lee J; Marshall JC; Devlin JW; Blackwood B; Needham DM; Siddiqi N; Page V;
Crit Care Med; 2021 Sep; 49(9):1535-1546. PubMed ID: 33870914
[TBL] [Abstract][Full Text] [Related]
28. Core Outcome Domains for early phase clinical trials of sound-, psychology-, and pharmacology-based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study protocol for using a Delphi process and face-to-face meetings to establish consensus.
Fackrell K; Smith H; Colley V; Thacker B; Horobin A; Haider HF; Londero A; Mazurek B; Hall DA
Trials; 2017 Aug; 18(1):388. PubMed ID: 28835261
[TBL] [Abstract][Full Text] [Related]
29. Core Domains for Clinical Research in Acute Respiratory Failure Survivors: An International Modified Delphi Consensus Study.
Turnbull AE; Sepulveda KA; Dinglas VD; Chessare CM; Bingham CO; Needham DM
Crit Care Med; 2017 Jun; 45(6):1001-1010. PubMed ID: 28375853
[TBL] [Abstract][Full Text] [Related]
30. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A;
Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170
[TBL] [Abstract][Full Text] [Related]
31. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
[TBL] [Abstract][Full Text] [Related]
32. Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1.
Chamseddin BH; Hernandez L; Solorzano D; Vega J; Le LQ
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31038470
[TBL] [Abstract][Full Text] [Related]
33. Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.
Merker VL; Thompson HL; Wolters PL; Buono FD; Hingtgen CM; Rosser T; Barton B; Barnett C; Smith T; Haberkamp D; McManus ML; Baldwin A; Moss IP; Röhl C; Martin S
Clin Trials; 2024 Feb; 21(1):6-17. PubMed ID: 38140900
[TBL] [Abstract][Full Text] [Related]
34. Core outcome domains for clinical trials in non-specific low back pain.
Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
[TBL] [Abstract][Full Text] [Related]
35. Development of reporting guidance and core outcome sets for seamless, standardised evaluation of innovative surgical procedures and devices: a study protocol for content generation and a Delphi consensus process (COHESIVE study).
Avery K; Blazeby J; Wilson N; Macefield R; Cousins S; Main B; Blencowe NS; Zahra J; Elliott D; Hinchliffe R; Potter S
BMJ Open; 2019 Sep; 9(9):e029574. PubMed ID: 31515426
[TBL] [Abstract][Full Text] [Related]
36. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
37. An international Delphi consensus process to determine a common data element and core outcome set for frailty: FOCUS (The Frailty Outcomes Consensus Project).
Prorok JC; Williamson PR; Shea B; Rolfson D; Mañas LR; Cesari M; Kim P; Muscedere J
BMC Geriatr; 2022 Apr; 22(1):284. PubMed ID: 35382752
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.
Guiraud M; Bouroubi A; Beauchamp R; Bocquet A; Grégoire JM; Rauly-Lestienne I; Blanco I; Wolkenstein P; Schmitt AM
Orphanet J Rare Dis; 2019 Dec; 14(1):286. PubMed ID: 31801570
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous neurofibromas: Current clinical and pathologic issues.
Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
[TBL] [Abstract][Full Text] [Related]
40. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
